Public Company News
Deepen Implementation of Building China-Laos Community with Shared Future and Jointly Build the " PUSUNE Digital College"
HONG KONG, Dec. 12, 2022 /PRNewswire/ -- On 12 December, Neusoft Education Technology Co. Limited (東軟教育科技有限公司) (hereinafter referred to as "Neusoft Education" or "the Company"; Stock code: 9616.HK) together with Pu`er University inYunnan and Laos Souphanouvong University, held a signing ceremony...
China Automotive Systems Launches New Electric Power Steering Systems for BYD
WUHAN, China, Dec. 12, 2022 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that it has introduced a new series of Electric Power Steering ("EPS") systems for the largest Ch...
Lanvin Group and Primavera Capital Acquisition Corporation Announce Shareholder Approval of Business Combination; Trade Debut Expected on NYSE on December 15 Under Ticker "LANV"
* Business Combination expected to close on December 14, 2022 * Lanvin Group expected to begin trading on NYSE on December 15, 2022 under ticker "LANV" SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Lanvin Group (the "Group"), a global luxury fashion group, and Primavera Capital Acquisition Corporat...
Moomoo SG observes asset influx to wealth management, Group's AUM hits SGD 5.27B
Wealth management continues to trend upwards in 2023 as more Singapore investors preserve their saving and purchasing capabilities. SINGAPORE, Dec. 12, 2022 /PRNewswire/ -- Moomoo SG's parent company Futu Holdings Limited (Nasdaq: FUTU) (Futu), a leading tech-driven digital brokerage and wealth ...
JinkoSolar's High-efficiency N-Type Monocrystalline Silicon Solar Cell Sets Our New Record with Maximum Conversion Efficiency of 26.4%
SHANGRAO, China, Dec. 12, 2022 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it has achieved a major technical breakthrough for its 182 mm high-efficien...
Five Types of Shoppers You'll Find This Holiday Season (and the Cyberscams They Must Watch Out For)
SINGAPORE, Dec. 12, 2022 /PRNewswire/ -- With the holidays around the corner, we're smack in the middle of every shopper's favourite season. Big sales days like Singles' Day, Black Friday, Cyber Monday, and 12.12 all offer many great opportunities for shoppers to get their fill of good deals. A...
JW Therapeutics Presents Latest Clinical Data on Carteyva® in Follicular Lymphoma and Mantle Cell Lymphoma at the 64th ASH Annual Meeting
SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, presented the latest clinical data on Carteyva® (relmacabtagene autoleucel injection) in...
Asieris Enrolled First Patient for its Phase II Clinical Study of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer
SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the first patient enrolled in phas...
EQT included in the Dow Jones Sustainability Index
STOCKHOLM, Dec. 12, 2022 /PRNewswire/ -- EQT AB ("EQT") has been selected for inclusion in the Dow Jones Sustainability Indices (DJSI) based on its results in the S&P Global Corporate Sustainability Assessment.EQT AB ("EQT") has been selected for inclusion in the Dow Jones Sustainability Indices ...
Alphamab Oncology Presented Clinical Data of KN026 Combined with Docetaxel in first-line treatment of HER2-positive recurrent/metastatic breast cancer at SABCS 2022
* As of August 18, 2022,the confirmed ORR for 55 evaluable subjects was 76.4% and DoR was 24.0 months. The disease control rate was 100% in 55 evaluable subjects. * The median follow-up for PFS was 16.6 months. The median PFS was calculated as 25.4 months and yet to become mature. * The med...
Hyundai Motor Group's HTWO Fuel Cell Technology to Provide Clean Power for FAUN's ENGINIUS Commercial Trucks
* The Group to supply fuel cell systems to ENGINIUS for mass production of commercial trucks for various purposes, such as waste collection and cargo delivery * Through HTWO's first partnership, the Group aims to lead the European eco-friendly waste collection vehicle sector with zero emissio...
Alphamab Oncology Presented Clinical Data of KN026 Combined with Docetaxel as neoadjuvant treatment for HER2-positive early or locally advanced breast cancer at SABCS 2022
* As of Sep 10, 2022, 20 patients completed the surgery and pathological evaluation, tpCR rate were 50%, bpCR rate were 55.0%, and ORR were 100%. * In terms of safety, the incidence Grade ≥3 TEAE were 53.3% (16/30)。The incidence of SAE was 6.7% (2/30) with only one case related to KN026. SUZHO...
China Telecom's Annual Report Received 17 Platinum and Gold Awards and Ranked No.10 of "Top 100 Reports Worldwide"
HONG KONG, Dec. 12, 2022 /PRNewswire/ -- China Telecom Corporation Limited ("China Telecom" or "the Company"; HKEx: 00728; SSE: 601728) is pleased to announce that the print and online versions of its 2021 Annual Report "A New Milestone" received 17 platinum and gold awards in total in various i...
Acer Listed on Dow Jones Sustainability Indices (DJSI) 2022; Achieves Its Highest Ranking in Nine Years
Recognized among industry leaders in the THQ Computers & Peripherals and Office Electronics category at No. 2 TAIPEI, Dec. 12, 2022 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced that it has been listed on the Dow Jones Sustainability Indices (DJSI) Emerging Markets Index in 2022 for the ninth...
JITC publication of Akeso's Ligufalimab(CD47 monoclonal antibody) mechanism shows promising antitumor efficacy and favorable safety profile
HONG KONG, Dec. 11, 2022 /PRNewswire/ -- Akeso Inc. (9926. HK) ("Akeso") today announced that the Journal for Immunotherapy of Cancer (JITC), a BMJ oncology journal, published the mechanism of action of its Ligufalimab (AK117).The article's name is "Ligufalimab, a novel anti-CD47 antibody with no...
Alphamab Oncology Presented Final Analysis of KN046 Combined with Nab-paclitaxel in the Treatment of mTNBC at SABCS 2022
* As of August 21, 2022, the ORR from 25 efficacy evaluable TNBC patients was 44.0%, the DCR was 96.0%, and the CBR was 52.0%. * The median follow-up time was 27.93 months. The median PFS was 7.33 months. Among the PD-L1 ≥1% pts, the median PFS was 8.61 months. * The median OS was not mature...
PLDT, Smart recognized for whole-of-nation approach to child protection, reinforcing sustainability
MANILA, Philippines, Dec. 12, 2022 /PRNewswire/ -- The recent Global Child Forum brought to the fore, best practices of private companies worldwide, including PLDT and Smart's whole-of-nation approach to safeguard children. Held at the Royal Palace in the presence of the King and Queen of Sweden,...
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery
CHENGDU, China, Dec. 11, 2022 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. ("Nitrase"), a biopharmaceutical company deploying its NITROME platform to buil...
Ribbon Appoints Channel UC as Partner and Distributor for Ribbon Connect for Microsoft Teams Direct Routing
Extends reach of cloud solutions in Australia/New Zealand Market SYDNEY, Dec. 12, 2022 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications software and IP optical networking solutions to service providers, enterprises, and critical infrastruct...
Innovent Presents Phase 1b Clinical Data of IBI188 (Anti-CD47 Monoclonal Antibody) at the 2022 American Society of Hematology Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, Dec. 11, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1183 media titles]
2026-11-13 22:11Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1170 media titles]
2026-11-12 23:00The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1168 media titles]
2026-11-14 13:23Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00